瘤学:你可能在2023年错过了什么
Courtney H Coschi1, Lorin Dodbiba1, DuPont Guerry2
1Division of Medical Oncology, Department of Medicine, McMaster University, Hamilton, Ontario, Canada (C.H.C., L.D.).
Annals of internal medicine
|April 15, 2024
概括
本综述涵盖了非瘤学家医生的2023年瘤学进展,重点关注癌症患者的社会干预,癌症查,激素治疗和COVID-19疫苗接种.
科学领域:
- 在瘤学瘤学.
- 内部医学 内部医学
- 公共卫生 公共卫生
背景情况:
- 癌症治疗的进步改善了患者的治疗结果和生活质量.
- 复杂的癌症治疗需要多学科的医生合作.
- 证据审查的目标是管理癌症患者的非瘤学家专家.
研究的目的:
- 突出2023年与瘤患者管理相关的重要出版物.
- 为内部医学专家和子专家提供关键更新.
- 综合跨不同瘤学相关主题的新证据.
主要方法:
- 2023年出版物的文学选.
- 专注于与非瘤专家相关的证据.
- 文章按主题分类:社会干预,查,治疗和COVID-19.
主要成果:
- 关于终身护理和护理人员福祉的社会干预措施的关键发现.
- 更新了针对结直肠和肺癌风险的查指南.
- 关于非侵入性乳腺瘤的安全激素相关疗法的证据.
- 关于COVID-19疫苗接种,治疗疼痛的大麻素使用,免疫检查点抑制剂副作用和第二次主要瘤的见解.
结论:
- 非瘤学家的医生需要对各种瘤学主题的最新知识.
- 社会决定因素和向疗法在癌症护理中至关重要.
- 目前正在进行的研究涉及生存率,不良影响和瘤学新出现的挑战.
更多相关视频
相关概念视频
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
Cancer Survival Analysis
345
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
345
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K


